Skip to content

Efficacy Confirmation Test for Regular Intake -Preliminary validation of efficacy (improvement of bowel movements, anti-obesity, immunomodulation) of lactobacilli intake in healthy subjects

Efficacy Confirmation Test for Regular Intake -Preliminary validation of efficacy (improvement of bowel movements, anti-obesity, immunomodulation) of lactobacilli intake in healthy subjects - Preliminary validation of efficacy (improvement of bowel movements, anti-obesity, immunomodulation) when lactic acid bacteria-containing foods are ingested

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000054286
Enrollment
40
Registered
2026-05-01
Start date
2024-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Take one tablet of the test food per day for 4 weeks One tablet of control food per day for 4 weeks

Sponsors

Tokai Gakuen University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: (1) Healthy Japanese women who are between 18 and 60 years of age at the time of consent. (2) Patients who are not receiving any treatment, whether seasonal, chronic, or sudden, by means of drugs, therapy, or treatment. (3) Participants who fully understand the content of the clinical research and agree in writing of their own free will to participate in this clinical research. (4) Patients whose body temperature is between 35.5 and 37.0. (5) Patients who are able to prohibit binge eating and drinking based on three meals a day during the period of this clinical research. (6) Patients who are able to use appropriate contraception during the period of this clinical research. (7) Patients who are able to understand and comply with the administrative rules during this clinical research period.

Exclusion criteria

Exclusion criteria: (1) Persons with diseases of the gastrointestinal tract, liver, kidney, heart, and circulatory system that affect absorption, distribution, metabolism, and excretion of the test food. (2) Patients with a history of major surgery on the gastrointestinal tract site such as gastrectomy, gastrointestinal suture, or intestinal resection (excluding polypectomy and appendectomy) (3) Those with a history of cerebrovascular disease (4) Those with hypersensitivity or specific constitution such as food allergy related to the test food (5) Patients suspected of alcohol or drug dependence (6) Patients who have participated in other clinical trials or clinical research within the past 84 days from the date of consent (7) Donated 400mL blood within the past 84 days, 200mL blood within the past 28 days, or donated blood components (plasma and platelet components) within the past 14 days from the date of consent. (8) Those who are lactating or pregnant. (9) Those who are engaged in night shift.

Design outcomes

Primary

MeasureTime frame
Allergy Score

Secondary

MeasureTime frame
Weight and body fat changes, bowel movement questionnaire

Countries

Japan

Contacts

Public ContactAtsuhisa Nishimura

ICHIBIKI Co., LTD. Research Laboratory

tecnicalcenter@ichibiki.co.jp0532328776

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026